vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Village Farms International, Inc. (VFF). Click either name above to swap in a different company.
FENNEC PHARMACEUTICALS INC. is the larger business by last-quarter revenue ($13.8M vs $12.2M, roughly 1.1× Village Farms International, Inc.). Village Farms International, Inc. runs the higher net margin — 19.9% vs -34.7%, a 54.6% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 31.5%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Grafton Village Cheese Company is a cheesemaker in the town of Grafton in the U.S. state of Vermont. The company produces hand-crafted aged cheddar cheese.
FENC vs VFF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $12.2M |
| Net Profit | $-4.8M | $2.4M |
| Gross Margin | — | — |
| Operating Margin | -18.5% | — |
| Net Margin | -34.7% | 19.9% |
| Revenue YoY | 73.8% | 31.5% |
| Net Profit YoY | -141.1% | 128.2% |
| EPS (diluted) | $-0.17 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $12.2M | ||
| Q3 25 | $12.5M | $66.7M | ||
| Q2 25 | $9.7M | $59.9M | ||
| Q1 25 | $8.8M | $77.1M | ||
| Q4 24 | $7.9M | — | ||
| Q3 24 | $7.0M | $54.9M | ||
| Q2 24 | $7.3M | $53.6M | ||
| Q1 24 | $25.4M | $78.1M |
| Q4 25 | $-4.8M | $2.4M | ||
| Q3 25 | $-638.0K | $10.2M | ||
| Q2 25 | $-3.2M | $26.5M | ||
| Q1 25 | $-1.2M | $-6.7M | ||
| Q4 24 | $-2.0M | — | ||
| Q3 24 | $-5.7M | $-820.0K | ||
| Q2 24 | $-5.6M | $-23.5M | ||
| Q1 24 | $12.8M | $-2.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | 47.9% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 14.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.8% | ||
| Q2 24 | — | 25.4% | ||
| Q1 24 | — | 19.9% |
| Q4 25 | -18.5% | — | ||
| Q3 25 | -1.5% | 23.3% | ||
| Q2 25 | -28.3% | 20.8% | ||
| Q1 25 | -9.2% | -8.0% | ||
| Q4 24 | -11.8% | — | ||
| Q3 24 | -74.6% | 3.8% | ||
| Q2 24 | -69.4% | -43.5% | ||
| Q1 24 | 54.2% | -3.0% |
| Q4 25 | -34.7% | 19.9% | ||
| Q3 25 | -5.1% | 15.3% | ||
| Q2 25 | -32.7% | 44.2% | ||
| Q1 25 | -13.3% | -8.7% | ||
| Q4 24 | -25.0% | — | ||
| Q3 24 | -82.2% | -1.5% | ||
| Q2 24 | -76.5% | -43.9% | ||
| Q1 24 | 50.6% | -3.7% |
| Q4 25 | $-0.17 | $0.01 | ||
| Q3 25 | $-0.02 | $0.08 | ||
| Q2 25 | $-0.11 | $0.24 | ||
| Q1 25 | $-0.04 | $-0.06 | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $-0.21 | $-0.01 | ||
| Q2 24 | $-0.20 | $-0.21 | ||
| Q1 24 | $0.41 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $81.2M |
| Total DebtLower is stronger | — | $33.7M |
| Stockholders' EquityBook value | $35.5M | $299.9M |
| Total Assets | $70.6M | $423.1M |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $81.2M | ||
| Q3 25 | $21.9M | $82.6M | ||
| Q2 25 | $18.7M | $60.0M | ||
| Q1 25 | $22.7M | $15.1M | ||
| Q4 24 | $26.6M | — | ||
| Q3 24 | $40.3M | $28.7M | ||
| Q2 24 | $43.1M | $29.7M | ||
| Q1 24 | $51.2M | $26.7M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $19.4M | $34.6M | ||
| Q2 25 | $19.4M | $39.1M | ||
| Q1 25 | $19.4M | $39.2M | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | $43.3M | ||
| Q2 24 | $31.8M | $44.4M | ||
| Q1 24 | $31.3M | $46.1M |
| Q4 25 | $35.5M | $299.9M | ||
| Q3 25 | $-4.5M | $295.4M | ||
| Q2 25 | $-7.5M | $284.3M | ||
| Q1 25 | $-5.9M | $248.3M | ||
| Q4 24 | $-5.9M | — | ||
| Q3 24 | $-5.2M | $274.4M | ||
| Q2 24 | $-1.4M | $275.2M | ||
| Q1 24 | $3.0M | $296.2M |
| Q4 25 | $70.6M | $423.1M | ||
| Q3 25 | $49.3M | $418.4M | ||
| Q2 25 | $44.9M | $403.7M | ||
| Q1 25 | $46.4M | $377.1M | ||
| Q4 24 | $44.9M | — | ||
| Q3 24 | $58.9M | $417.8M | ||
| Q2 24 | $63.2M | $425.4M | ||
| Q1 24 | $69.2M | $458.4M |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.14× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | 10.40× | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 90.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $1.5M | $24.4M | ||
| Q2 25 | $-3.7M | — | ||
| Q1 25 | $-4.3M | $-6.4M | ||
| Q4 24 | $-1.5M | — | ||
| Q3 24 | $-2.2M | $4.3M | ||
| Q2 24 | $-8.4M | $5.7M | ||
| Q1 24 | $39.0M | $-50.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | $22.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-8.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | $4.8M | ||
| Q1 24 | — | $-1.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | 33.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -11.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 9.0% | ||
| Q1 24 | — | -2.5% |
| Q4 25 | — | 90.8% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.1% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FENC
Segment breakdown not available.
VFF
| International Sales | $8.7M | 71% |
| Cannabis United States Segment | $3.4M | 27% |
